Apoptosis in systemic lupus erythematosus

Harefuah

Volumn 142, Issue 12, 2003, Pages 844-847+876

  Marai, Ibrahim ^a   Zandman Goddard, Gisele ^a   Sheonfeld, Yehuda ^a  

^a NONE

Author keywords

Apoptosis; Autoimmune lymphoproliferative syndrome; Systemic lupus erythematosus; TNFR associated periodic syndrome

Indexed keywords

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DEATH; HUMAN; IMMUNE RESPONSE; PATHOGENESIS; PHAGOCYTOSIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

APOPTOSIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0345907938     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Ashkenazi A & Dixit VM, Death receptors: signaling and modulation. Science, 1998; 281: 1305-1308.
2. Wyllie AH, Kerr JF & Currie AR, Cell death: the significance of apoptosis. Int Rev Cytol, 1980; 68: 251-306.
3. Bijl M, Limburg PC & Kallenberg C, New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis. Neth J Med, 2001; 59: 66-75.
4. Nagata S, Fas ligand-induced apoptosis. Annu Rev Genet, 1999; 33: 29-55.
5. Miyawaki T, Uehara T, Nibu R & al, Differential expression of apoptosis-realted Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol, 1992; 149: 3753-3758.
6. Adams JM & Cory S, The Bcl-2 protein family: arbiters of cell survival. Science, 1998; 281: 1322-1326.
7. Andrade F, Roy S, Nicholson D & al, Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity, 1996; 8: 451-460.
8. Cohen JJ, Duke RC, Fadok VA & al, Apoptosis and programmed cell death in immunity. Annu Rev Immunol, 1992; 10: 267-293.
9. Rose LM, Latchman DS & Isenberg DA, Elevated soluble fas production in SLE correlates with HLA status not with disease activity. Lupus, 1997; 6: 717-722.
10. Casiola-Rosen LA, Anhalt G & Rosen A, Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med, 1994; 179: 1317-1330.
11. Devitt A, Moffatt OD, Raykundalia C & al, Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature, 1998; 392: 505-509.
12. Gershov D, Kim S, Brot N & al, C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response. Implications for systemic autoimmunity. J Exp Med, 2000; 192: 1353-1364.
13. Greidinger EL, Apoptosis in lupus pathogenesis. Frontiers in Bioscience, 2001; 6: 1392-1402.
14. Wu X, Molinaro C, Johnson N & al, Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens. Arthritis Rheum, 2001; 44: 2642-2652.
15. Ronchetti A, Iezzi G, Crosti MC & al, Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells. J Leukoc Biol, 1999; 66: 247-251.
16. Mevorach D, Zhou JL & Song X, Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med, 1998; 188: 387-392.
17. Malmegrim KC, Pruijn GJ & van Venrooij WJ, the fate of U1 snRNP autoantigen during apoptosis: implication for systemic autoimmunity. Isr Med Assoc J, 2002; 4: 706-712.
18. Griffin DE & Hardwick JM, Regulators of apoptosis on the road to persistent alpha-virus infection. Annu Rev Microbiol, 1997; 51: 565-592.
19. Taylor PR, Carugati A, Fadok VA & al, A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med, 2000; 192: 359-366.
20. Zandman-Goddard G & Blank M, Apoptosis and autoimmunity. Isr Med Assoc J, 2002: 4; 722-724.
21. Kumagai S, Steinberg AD & Green I, Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells. J Clin Invest, 1981; 67: 605-614.
22. Fisher GH, Rosenberg FJ, Straus SE & al, Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell, 1995; 81: 935-946.
23. Straus SE, Sneller M, Lenardo MJ & al, An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Int Med, 1999; 130: 591-601.
24. Lim MS, Straus SE, Dale JK &t al, Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol, 1998; 153: 1541-1550.
25. Huang B, Eberstadt M, Olejniczak ET & al, NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature, 1996; 384: 638-641.
26. Infante AJ, Britton HA, DeNapoli T & al, The clinical spectrum in large kindred with autoimmune lymphoproliferatve syndrome due to a Fas mutation that impairs lymphocyte apoptosis. J Pediat, 1998; 133: 629-633.
27. Dod C, Papo T, Fieschi C & al, A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family. Arthrit Rheum, 2000; 43: 1535-1542.
28. McDermott MF, Aksentijevich I, Galon J & al, Germline mutations in the extracellular domains of the 55kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell, 1999; 97: 133-144.